title: Second biannual report of the Cochrane Haematological Malignancies Group.
authors.affiliation: Cochrane Haematological Malignancies Group, Cologne, Germany. thilo.kober@medizin.uni-koeln.de
authors.forename: Thilo
authors.initials: T
authors.lastname: Kober
authors.forename: Julia
authors.initials: J
authors.lastname: Bohlius
authors.forename: Sven
authors.initials: S
authors.lastname: Trelle
authors.forename: Andreas
authors.initials: A
authors.lastname: Engert
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D019337:Hematologic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D033581:Stem Cell Transplantation; D016896:Treatment Outcome